Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01775384
Other study ID # 12-0134
Secondary ID
Status Completed
Phase N/A
First received January 2, 2013
Last updated January 22, 2013
Start date April 2012
Est. completion date December 2012

Study information

Verified date January 2013
Source Appalachian State University
Contact n/a
Is FDA regulated No
Health authority USA: Appalachian State University Institutional Review Board
Study type Interventional

Clinical Trial Summary

Nutrasorb is a newly developed food product (see www.nutrasorb.com). This study will use the Nutrasorb soy protein product that is matrixed with polyphenols from blueberries and green tea extract, and test for efficacy as a nutritional countermeasure to exercise-induced physiologic stress (i.e., immune dysfunction, inflammation, and oxidative stress) using both traditional and metabolomics-based outcome measures.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date December 2012
Est. primary completion date November 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- Male or female endurance athletes; competitive runners or cyclists

- Capable of exercising for 2.5 h at a high intensity in the lab

- Ages 18-55

- Agree to train normally and stay weight stable.

- Agree to avoid the use of large dose vitamin/mineral supplements

- Agree to avoid herbs and medications that influence inflammation

Exclusion Criteria:

- Regularly take supplements or medicines known to effect inflammation.

- At moderate or high risk for cardiovascular disease.

- Younger than 18 or older than 55 years of age.

- No history of competing in long distance running and cycling races.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Nutrasorb
from blueberry and green tea extracts (2,136 mg/d gallic acid equivalents)
Placebo


Locations

Country Name City State
United States ASU Human Performance Laboratory, North Carolina Research Campus Kannapolis North Carolina

Sponsors (2)

Lead Sponsor Collaborator
Appalachian State University Dole Food Company

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Metabolomics; change in metabolites over time GC-MS and LC-MS through Metabolon 18-day period; Blood samples collected pre- and post-14 d supplementation, and immediately and 14 h after the third day of running No
Secondary Change in inflammation CRP and a cytokine panel 18-day period; Blood samples collected pre- and post-14 d supplementation, and immediately and 14 h after the third day of running No
Secondary Change in oxidative stress F2-isoprostanes, protein carbonyls, FRAP, ORAC 18-day period; Blood samples collected pre- and post-14 d supplementation, and immediately and 14 h after the third day of running No
Secondary Change in immune function Anti-viral activity using virus-infected HeLa cells 18-day period; Blood samples collected pre- and post-14 d supplementation, and immediately and 14 h after the third day of running No
See also
  Status Clinical Trial Phase
Completed NCT03259412 - Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance N/A
Completed NCT03205241 - Effect of 4 Weeks Fish Oil Supplementation on Cycling Performance in Healthy Male Cyclists N/A

External Links